Zobrazeno 1 - 10 of 284 pro vyhledávání: '"Zaragori T"'
1
Akademický článek
The role of [18 F]FDOPA PET as an adjunct to conventional MRI in the diagnosis of aggressive glial lesions.
Autor: Zinsz A; Department of Nuclear Medicine & Nancyclotep Imaging Platform, CHRU-Nancy, Université de Lorraine, Nancy, F-54000, France., Pouget C; Department of Pathology, CHRU-Nancy, Université de Lorraine, Nancy, CP, France.; INSERM U1256, Université de Lorraine, Nancy, CP, France., Rech F; Department of Neurosurgery, CHRU-Nancy, Université de Lorraine, Nancy, FR, France.; Centre de Recherche en Automatique de Nancy CRAN UMR 7039, CNRS, Université de Lorraine, Nancy, France., Taillandier L; Centre de Recherche en Automatique de Nancy CRAN UMR 7039, CNRS, Université de Lorraine, Nancy, France.; Department of Neuro-Oncology, CHRU-Nancy, Université de Lorraine, Nancy, LT, MB, France., Blonski M; Centre de Recherche en Automatique de Nancy CRAN UMR 7039, CNRS, Université de Lorraine, Nancy, France.; Department of Neuro-Oncology, CHRU-Nancy, Université de Lorraine, Nancy, LT, MB, France., Amlal S; Department of Neuro-Radiology, CHRU-Nancy, Université de Lorraine, Nancy, SA, France., Imbert L; Department of Nuclear Medicine & Nancyclotep Imaging Platform, CHRU-Nancy, Université de Lorraine, Nancy, F-54000, France.; INSERM, IADI, UMR 1254 Université de Lorraine, Nancy, F-54000, France., Zaragori T; Department of Nuclear Medicine & Nancyclotep Imaging Platform, CHRU-Nancy, Université de Lorraine, Nancy, F-54000, France.; INSERM, IADI, UMR 1254 Université de Lorraine, Nancy, F-54000, France., Verger A; Department of Nuclear Medicine & Nancyclotep Imaging Platform, CHRU-Nancy, Université de Lorraine, Nancy, F-54000, France. a.verger@chru-nancy.fr.; INSERM, IADI, UMR 1254 Université de Lorraine, Nancy, F-54000, France. a.verger@chru-nancy.fr.; Médecine Nucléaire, Hôpital de Brabois, CHRU- Nancy, Allée du Morvan, Vandoeuvre-les-Nancy, 54500, France. a.verger@chru-nancy.fr.
Publikováno v: European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2024 Jul; Vol. 51 (9), pp. 2672-2683. Date of Electronic Publication: 2024 Apr 19.
Zobrazit plný text záznamu
2
Akademický článek
Application of PET imaging delta radiomics for predicting progression-free survival in rare high-grade glioma.
Autor: Ahrari S; Imagerie Adaptative Diagnostique et Interventionnelle, Institut National de la Santé et de la Recherche Médicale U1254, Université de Lorraine, 54000, Nancy, France.; Nancyclotep Imaging Platform, Université de Lorraine, 54000, Nancy, France., Zaragori T; Imagerie Adaptative Diagnostique et Interventionnelle, Institut National de la Santé et de la Recherche Médicale U1254, Université de Lorraine, 54000, Nancy, France.; Nancyclotep Imaging Platform, Université de Lorraine, 54000, Nancy, France., Zinsz A; Department of Nuclear Medicine, Centre Hospitalier Régional Universitaire de Nancy, 54000, Nancy, France., Oster J; Imagerie Adaptative Diagnostique et Interventionnelle, Institut National de la Santé et de la Recherche Médicale U1254, Université de Lorraine, 54000, Nancy, France., Imbert L; Imagerie Adaptative Diagnostique et Interventionnelle, Institut National de la Santé et de la Recherche Médicale U1254, Université de Lorraine, 54000, Nancy, France.; Nancyclotep Imaging Platform, Université de Lorraine, 54000, Nancy, France.; Department of Nuclear Medicine, Centre Hospitalier Régional Universitaire de Nancy, 54000, Nancy, France., Verger A; Imagerie Adaptative Diagnostique et Interventionnelle, Institut National de la Santé et de la Recherche Médicale U1254, Université de Lorraine, 54000, Nancy, France. a.verger@chru-nancy.fr.; Nancyclotep Imaging Platform, Université de Lorraine, 54000, Nancy, France. a.verger@chru-nancy.fr.; Department of Nuclear Medicine, Centre Hospitalier Régional Universitaire de Nancy, 54000, Nancy, France. a.verger@chru-nancy.fr.
Publikováno v: Scientific reports [Sci Rep] 2024 Feb 08; Vol. 14 (1), pp. 3256. Date of Electronic Publication: 2024 Feb 08.
Zobrazit plný text záznamu
3
Akademický článek
177Lu-labeled somatostatin receptor targeted radionuclide therapy dosimetry in meningioma: a systematic review.
Autor: Boursier C; Department of Nuclear Medicine, CHRU-Nancy, University of Lorraine, Nancy, France - c.boursier@chru-nancy.fr.; IADI, INSERM U1254, University of Lorraine, Nancy, France - c.boursier@chru-nancy.fr.; Nancyclotep Imaging Platform, Nancy, France - c.boursier@chru-nancy.fr., Zaragori T; CIC1433, Innovation Technologique, Inserm, CHRU Nancy, University of Lorraine, Nancy, France., Imbert L; Department of Nuclear Medicine, CHRU-Nancy, University of Lorraine, Nancy, France.; IADI, INSERM U1254, University of Lorraine, Nancy, France.; Nancyclotep Imaging Platform, Nancy, France., Verger A; Department of Nuclear Medicine, CHRU-Nancy, University of Lorraine, Nancy, France.; IADI, INSERM U1254, University of Lorraine, Nancy, France.; Nancyclotep Imaging Platform, Nancy, France.
Publikováno v: The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of.. [Q J Nucl Med Mol Imaging] 2024 Sep; Vol. 68 (3), pp. 217-225. Date of Electronic Publication: 2024 Jul 19.
Zobrazit plný text záznamu
4
Akademický článek
Amino-acid PET as a prognostic tool after post Stupp protocol temozolomide therapy in high-grade glioma patients.
Autor: Zinsz A; Department of Nuclear Medicine and Nancyclotep Imaging Platform, Université de Lorraine, CHRU Nancy, 54000, Nancy, France., Ahrari S; Université de Lorraine, IADI, INSERM U1254, F-54000, Nancy, France., Becker J; Department of Neuro-Oncology, Université de Lorraine, CHRU Nancy, 54000, Nancy, France., Mortada A; Department of Nuclear Medicine and Nancyclotep Imaging Platform, Université de Lorraine, CHRU Nancy, 54000, Nancy, France., Roch V; Department of Nuclear Medicine and Nancyclotep Imaging Platform, Université de Lorraine, CHRU Nancy, 54000, Nancy, France., Doriat L; Department of Nuclear Medicine and Nancyclotep Imaging Platform, Université de Lorraine, CHRU Nancy, 54000, Nancy, France., Santi M; Department of Nuclear Medicine and Nancyclotep Imaging Platform, Université de Lorraine, CHRU Nancy, 54000, Nancy, France., Blonski M; Department of Neuro-Oncology, Université de Lorraine, CHRU Nancy, 54000, Nancy, France., Taillandier L; Department of Neuro-Oncology, Université de Lorraine, CHRU Nancy, 54000, Nancy, France., Zaragori T; Department of Nuclear Medicine and Nancyclotep Imaging Platform, Université de Lorraine, CHRU Nancy, 54000, Nancy, France., Verger A; Department of Nuclear Medicine and Nancyclotep Imaging Platform, Université de Lorraine, CHRU Nancy, 54000, Nancy, France. a.verger@chru-nancy.fr.; Université de Lorraine, IADI, INSERM U1254, F-54000, Nancy, France. a.verger@chru-nancy.fr.; Nuclear Medicine Department, CHRU Nancy, Rue du Morvan, 54500, Vandoeuvre Les Nancy, France. a.verger@chru-nancy.fr.
Publikováno v: Journal of neuro-oncology [J Neurooncol] 2024 Sep; Vol. 169 (2), pp. 241-245. Date of Electronic Publication: 2024 Jun 06.
Zobrazit plný text záznamu
5
Akademický článek
Differentiating high-grade glioma progression from treatment-related changes with dynamic [ 18 F]FDOPA PET: a multicentric study.
Autor: Rozenblum L; Department of Nuclear Medicine and LIB, INSERM U1146, Sorbonne Université, AP-HP, Hôpitaux Universitaires Pitié-Salpêtrière Charles Foix, 47-83 boulevard de l'hôpital, 75013, Paris, France. Laura.rozenblum@aphp.fr., Zaragori T; Department of Nuclear Medicine & Nancyclotep Imaging platform, Université de Lorraine, CHRU-Nancy, F-54000, Nancy, France.; IADI, INSERM, UMR 1254, Université de Lorraine, F-54000, Nancy, France., Tran S; Department of Neuropathology, Groupe Hospitalier Pitié-Salpêtrière, APHP, Sorbonne Université, Paris, France., Morales-Martinez A; Department of Neuro-Oncology, Hôpital Pitié-Salpêtrière, Assistance Publique-Hôpitaux de Paris, Sorbonne Université, Paris, France., Taillandier L; Department of Neuro-Oncology, Université de Lorraine, CHRU-Nancy and CRAN, CNRS UMR 7039, F-54000, Nancy, France., Blonski M; Department of Neuro-Oncology, Université de Lorraine, CHRU-Nancy and CRAN, CNRS UMR 7039, F-54000, Nancy, France., Rech F; Department of Neurosurgery, Université de Lorraine, CHRU-Nancy, F-54000, Nancy, France., Galanaud D; Neuroradiology Department, Hôpital Pitié-Salpêtrière, Pitié-Salpêtrière Hospital, AP-HP Sorbonne Université, Sorbonne Université, Paris, France., Kas A; Department of Nuclear Medicine and LIB, INSERM U1146, Sorbonne Université, AP-HP, Hôpitaux Universitaires Pitié-Salpêtrière Charles Foix, 47-83 boulevard de l'hôpital, 75013, Paris, France., Verger A; Department of Nuclear Medicine & Nancyclotep Imaging platform, Université de Lorraine, CHRU-Nancy, F-54000, Nancy, France.; IADI, INSERM, UMR 1254, Université de Lorraine, F-54000, Nancy, France.
Publikováno v: European radiology [Eur Radiol] 2023 Apr; Vol. 33 (4), pp. 2548-2560. Date of Electronic Publication: 2022 Nov 11.
Zobrazit plný text záznamu
6
Akademický článek
Semi-automated segmentation methods of SSTR PET for dosimetry prediction in refractory meningioma patients treated by SSTR-targeted peptide receptor radionuclide therapy.
Autor: Boursier C; Department of Nuclear Medicine, Université de Lorraine, CHRU Nancy, F-54000, Nancy, France. c.boursier@chru-nancy.fr.; Université de Lorraine, IADI, INSERM U1254, F-54000, Nancy, France. c.boursier@chru-nancy.fr.; Nancyclotep Imaging Platform, F-54000, Nancy, France. c.boursier@chru-nancy.fr., Zaragori T; Université de Lorraine, IADI, INSERM U1254, F-54000, Nancy, France., Bros M; Department of Nuclear Medicine, Université de Lorraine, CHRU Nancy, F-54000, Nancy, France., Bordonne M; Department of Nuclear Medicine, Université de Lorraine, CHRU Nancy, F-54000, Nancy, France., Melki S; Department of Nuclear Medicine, Université de Lorraine, CHRU Nancy, F-54000, Nancy, France., Taillandier L; Department of Neuro-Oncology, Université de Lorraine, CHRU Nancy, F-54000, Nancy, France.; Centre de Recherche en Automatique de Nancy CRAN, UMR 7039, Université de Lorraine, CNRS, F-54000, Nancy, France., Blonski M; Department of Neuro-Oncology, Université de Lorraine, CHRU Nancy, F-54000, Nancy, France.; Centre de Recherche en Automatique de Nancy CRAN, UMR 7039, Université de Lorraine, CNRS, F-54000, Nancy, France., Roch V; Department of Nuclear Medicine, Université de Lorraine, CHRU Nancy, F-54000, Nancy, France.; Nancyclotep Imaging Platform, F-54000, Nancy, France., Marie PY; Department of Nuclear Medicine, Université de Lorraine, CHRU Nancy, F-54000, Nancy, France.; Université de Lorraine, IADI, INSERM U1254, F-54000, Nancy, France.; Nancyclotep Imaging Platform, F-54000, Nancy, France., Karcher G; Department of Nuclear Medicine, Université de Lorraine, CHRU Nancy, F-54000, Nancy, France.; Nancyclotep Imaging Platform, F-54000, Nancy, France., Imbert L; Department of Nuclear Medicine, Université de Lorraine, CHRU Nancy, F-54000, Nancy, France.; Université de Lorraine, IADI, INSERM U1254, F-54000, Nancy, France.; Nancyclotep Imaging Platform, F-54000, Nancy, France., Verger A; Department of Nuclear Medicine, Université de Lorraine, CHRU Nancy, F-54000, Nancy, France.; Université de Lorraine, IADI, INSERM U1254, F-54000, Nancy, France.; Nancyclotep Imaging Platform, F-54000, Nancy, France.
Publikováno v: European radiology [Eur Radiol] 2023 Oct; Vol. 33 (10), pp. 7089-7098. Date of Electronic Publication: 2023 May 06.
Zobrazit plný text záznamu
7
Editorial & Opinion
Dynamic amino-acid PET in neuro-oncology: a prognostic tool becomes essential.
Autor: Verger A; Department of Nuclear Medicine & Nancyclotep Imaging Platform, CHRU-Nancy, Université de Lorraine, F-54000, Nancy, France. a.verger@chru-nancy.fr.; INSERM, IADI, UMR 1254 Université de Lorraine, F-54000, Nancy, France. a.verger@chru-nancy.fr.; Médecine Nucléaire, Hôpital de Brabois, CHRU-Nancy, Allée du Morvan, 54500, Vandoeuvre-les-Nancy, France. a.verger@chru-nancy.fr., Imbert L; Department of Nuclear Medicine & Nancyclotep Imaging Platform, CHRU-Nancy, Université de Lorraine, F-54000, Nancy, France.; INSERM, IADI, UMR 1254 Université de Lorraine, F-54000, Nancy, France., Zaragori T; Department of Nuclear Medicine & Nancyclotep Imaging Platform, CHRU-Nancy, Université de Lorraine, F-54000, Nancy, France.; INSERM, IADI, UMR 1254 Université de Lorraine, F-54000, Nancy, France.
Publikováno v: European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2021 Dec; Vol. 48 (13), pp. 4129-4132.
Zobrazit plný text záznamu
8
Report
Identification of resting-state networks using dynamic brain perfusion SPECT imaging: A fSPECT case report.
Autor: Doyen M; Department of Nuclear Medicine and Nancyclotep Imaging Platform, CHRU Nancy, Université de Lorraine, Nancy, France.; IADI, INSERM U1254, Université de Lorraine, Nancy, France., Hossu G; IADI, INSERM U1254, Université de Lorraine, Nancy, France.; CHRU-Nancy, INSERM, CIC, Innovation Technologique, Université de Lorraine, Nancy, France., Heyer S; Department of Nuclear Medicine and Nancyclotep Imaging Platform, CHRU Nancy, Université de Lorraine, Nancy, France., Zaragori T; IADI, INSERM U1254, Université de Lorraine, Nancy, France., Imbert L; Department of Nuclear Medicine and Nancyclotep Imaging Platform, CHRU Nancy, Université de Lorraine, Nancy, France.; IADI, INSERM U1254, Université de Lorraine, Nancy, France., Verger A; Department of Nuclear Medicine and Nancyclotep Imaging Platform, CHRU Nancy, Université de Lorraine, Nancy, France.; IADI, INSERM U1254, Université de Lorraine, Nancy, France.
Publikováno v: Frontiers in human neuroscience [Front Hum Neurosci] 2023 Apr 20; Vol. 17, pp. 1125765. Date of Electronic Publication: 2023 Apr 20 (Print Publication: 2023).
Zobrazit plný text záznamu
9
Akademický článek
Photopenic Defects in Gliomas With Amino-Acid PET and Relative Prognostic Value: A Multicentric 11C-Methionine and 18F-FDOPA PET Experience.
Autor: Zaragori T, Castello A; Nuclear Medicine Department, Humanitas Clinical and Research Hospital-IRCCS, Rozzano, Italy., Guedj E, Girard A; Department of Nuclear Medicine, Eugène Marquis Center, Rennes 1 University, Rennes, France., Galldiks N, Albert NL; Department of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany., Lopci E; Nuclear Medicine Department, Humanitas Clinical and Research Hospital-IRCCS, Rozzano, Italy., Verger A
Publikováno v: Clinical nuclear medicine [Clin Nucl Med] 2021 Jan; Vol. 46 (1), pp. e36-e37.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje